Investing

CareDx : CDNA

CDNA

Stock Data

$47.31

$0.08 (0.17%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DIAGNOSTICS & RESEARCH

CareDx, Inc. specializes in creating diagnostic solutions tailored for transplant patients, offering a suite of products that monitor the health and acceptance of organ transplants. Their innovative offerings include AlloSure for kidney, heart, and lung transplant patients, which uses donor-derived cell-free DNA to detect organ rejection. Additionally, CareDx provides AlloMap Heart, a gene expression test for heart transplant recipients, and a range of HLA typing solutions like Olerup SSP and QTYPE. They also offer Ottr, a software for managing transplant patients, and AlloCare, a mobile app designed to support transplant recipients' journeys. Headquartered in South San Francisco, California, CareDx serves its products globally, directly and through distributors.

Latest Activity

CDNACareDx, Inc.

Q2 2026

Jul 30, 4:03pm ET

EPS

$0.37

est $0.23+59.5%

Revenue

$132M

est $114M+15.7%

CareDx demolished EPS expectations with a 59% beat and raised full-year guidance after Testing Services revenue surged 61% to $99.93 million, powered by accelerating molecular surveillance adoption and a strategic lab divestiture that swelled cash reserves to $373.6 million.

ShareRead more

All CareDx Articles

2 Articles

Lee Jackson | Jun 17, 2023 at 6:05 AM EDT

5 of Cathie Wood’s Sizzling ARK Investment Stocks Are Buy Rated and Trading Under $10

These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential.…

Chris Lange | Jul 20, 2021 at 12:32 PM EDT

Apple, Array Tech, Vertex Pharma and More Tuesday Afternoon Analyst Calls

24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including Apple, Array…